Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 7 05:05

Express News | Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BreakingsDec 7 05:05

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Shares Fly 27% But Investors Aren't Buying For Growth

Simply Wall StDec 3 18:14

RBC Capital Remains a Hold on Apellis Pharmaceuticals (APLS)

TipRanksNov 28 09:48 · Ratings

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Apellis PharmaceuticalsNov 27 13:00

A Glimpse Into The Expert Outlook On Apellis Pharmaceuticals Through 20 Analysts

BenzingaNov 21 20:00